HCCI partners with Blue Health Intelligence

The Health Care Cost Institute, which holds one of the largest databases about the commercially insured population and publishes data reports, has partnered with Blue Health Intelligence to bolster data and research insights.

BHI carries medical and pharmacy claims data from more than 190 million Americans, representing Blue Cross and Blue Shield company members, and leverages that data to help healthcare organizations improve care, lower costs and optimize performance. HCCI’s dataset includes data from more than 60 million commercially-insured people annually. BHI’s data does not include identifying information about patients.

"By adding our conformed and secure data to HCCI's existing repository by the end of this year, BHI welcomes the chance to increase opportunities to advance healthcare cost and quality solutions for all Americans," Swati Abbott, CEO of BHI, said in a statement.

The partnership will increase HCCI’s ability to provide insights reports about employer-sponsored and individual insurance markets. The partnership comes after HCCI announced it would end its data sharing agreement with UnitedHealthcare at the beginning of 2019. HCCI receives de-identified patient data from several other major insurers.

"HCCI data has become an indispensable source of insight for the nation's leading academic institutions, such as Harvard, Cornell and Yale, as well as blue-ribbon health care analytic organizations, including the Congressional Budget Office, the Federal Trade Commission and Centers for Medicare and Medicaid Services (CMS) Office of the Actuary," Robert J. Town, PhD, chair of HCCI's Governing Board, said in a statement. "The continued availability and expansion of this data source will allow us to continue to better understand health system performance."

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.